Back to dashboard
Episode 187
DIP Episode 187 - USMLE Step 2CK Rapid Review Series 25
PharmacologyMedium4 - HighHas Q&A
Step 2Step 3MedicineUSMLEStep 2Step 3
Topic
Immunodeficiency syndromes (Hyper-IgM, CGD, LAD); Genetic disorders (Prader-Willi/Angelman Syndrome, DiGeorge Syndrome); Pharmacology of anti-psychotics...
Key Takeaway
High-yield board topics include recognizing the specific cell type affected in immunodeficiencies, understanding the genetic basis and imprinting patterns of syndromes like Prader-Willi/Angelman syndrome, recalling drug side effects associated with anti-psychotics (e.g., Clozapine -> myocarditis), and mastering the pathophysiology and management of cardiovascular conditions like heart failure.
Runtime: 26.9 min
Published: 2019-11-27
Completed audio: Yes
Completed notes: Yes
Anki made: Yes
Section: RAPID REVIEW SERIES
Episode Notes
Source / episode info
- Episode: 187
- Title: Divine Intervention Episode 187 – USMLE Step 2 CK Rapid Review Series 25.
- Published: 2019-11-27
- Source: Episode page
One-liner
This rapid review covers critical high-yield topics including immunodeficiencies (Hyper-IgM, CGD, LAD), genetic syndromes involving genomic imprinting (Prader-Willi/Angelman), drug toxicities from anti-psychotics (Clozapine, Quetiapine), cardiovascular management of heart failure, and neuromuscular disorders like Lambert-Eaton syndrome.
High-yield summary
- Hyper-IgM Syndrome: Caused by defects in class switching, often due to impaired CD40/CD40 L interaction; results in low IgG, IgA, and IgE, but normal or elevated IgM.
- CGD: X-linked recessive disorder affecting neutrophils due to NADPH oxidase deficiency; treated with Interferon gamma.
- DiGeorge Syndrome: Caused by deletion of chromosome 22q11; leads to T-cell immunodeficiency (due to pharyngeal pouch defects) and hypocalcemia/hypoparathyroidism.
- Prader-Willi/Angelman Syndromes: Both involve genomic imprinting on chromosome 15; PWS is associated with paternal gene loss, while AS is associated with maternal gene loss.
- Heart Failure Management: Key drugs include ACE inhibitors, AR Bs, Mineralocorticoid Receptor Antagonists (MR As), and Beta-blockers; Spironolactone carries a risk of gynecomastia due to androgen receptor antagonism.
- Anti-psychotic Toxicities: Clozapine -> Myocarditis/Dilated Cardiomyopathy; Quetiapine -> Cataract ("Quinaurex"); Olanzapine -> Metabolic Syndrome.
Learning objectives
- Identify the specific cell type affected in major immunodeficiency syndromes (e.g., neutrophils in CGD, T cells in DiGeorge).
- Differentiate between genetic disorders involving genomic imprinting and uniparental disomy (PWS vs Angelman).
- Recognize the clinical manifestations and associated drug toxicities of anti-psychotic medications.
- Understand the pathophysiology and management principles for heart failure using RAAS inhibitors and beta-blockers.
- Correlate specific physical exam findings or lab results with neuromuscular junction disorders (e.g., LEMS, HAE).
Board exam buzzwords
| Condition | Key Finding | Association | Board Exam Tip |
| Hyper-IgM Syndrome | Low IgG/IgA/IgE; High IgM | CD40/CD40 L defect | Think of impaired class switching. |
| Prader-Willi Syndrome (PWS) | Obesity, mild ID, almond eyes | Paternal gene loss on Chr 15 | The classic presentation is hyperphagia leading to obesity. |
| Hereditary Angioedema (HAE) | Recurrent angioedema; Low C2/C4 | C1 esterase inhibitor deficiency -> Bradykinin excess | Treatment involves bradykinin receptor antagonists (e.g., Icatiband). |
| Clozapine | Myocarditis, Dilated Cardiomyopathy | Anti-psychotic toxicity | This is a critical drug side effect to memorize for board exams. |
Rapid review table
| Topic | Key Point | Context | Exam Relevance |
| Immunodeficiency | Specific cell type affected (e.g., T cells, neutrophils) | Knowing the primary defect helps narrow the diagnosis (e.g., DiGeorge -> T-cell). | High yield for board questions; always ask "what is defective?" |
| Genomic Imprinting | Gene expression depends on parent of origin (Maternal vs Paternal) | Prader-Willi/Angelman syndromes are classic examples of imprinting disorders. | Test your understanding of which parent's gene is active or lost in a given sex. |
| Heart Failure Drugs | RAAS blockade and Beta-blockade | These classes improve survival by reducing cardiac remodeling and afterload. | Know the specific side effects (e.g., Spironolactone -> gynecomastia). |
| Neuromuscular Junctions | Autoantibodies against presynaptic Ca++ channels | LEMS is characterized by a failure of neurotransmitter release, often worsened by exercise/standing up. | Diagnosis relies on electrophysiology studies (EMG/NCS) showing facilitation with high-frequency stimulation. |
Board-speak -> diagnosis
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A child presents with recurrent infections, poor umbilical cord separation, and a mutation in the CD18 gene. | Leukocyte Adhesion Deficiency (LAD) | LAD impairs neutrophil adhesion to endothelium due to defective -2 integrin, leading to severe infection/inflammation and bleeding diathesis. |
| A male infant is found to have hypocalcemic seizures, tetralogy of Fallot, and a history suggestive of poor development in the pharyngeal arches. | DiGeorge Syndrome (22q11 deletion) | The 3rd and 4th pharyngeal pouches are critical for parathyroid gland formation (hypoparathyroidism -> hypocalcemia) and T-cell maturation (T-cell defect). |
| A patient with heart failure is started on spironolactone, which subsequently causes breast enlargement. | Mineralocorticoid Receptor Antagonism / Spironolactone side effect | Spironolactone acts as an androgen receptor antagonist in addition to blocking aldosterone receptors, leading to gynecomastia. Eplerenone avoids this risk. |
| A young male patient presents with severe obesity, mild intellectual disability, and almond-shaped eyes; the genetic testing reveals a deletion of paternal genes on chromosome 15. | Prader-Willi Syndrome (PWS) | PWS is linked to loss of paternally expressed genes on chromosome 15q11-q13. |
| A patient with chronic abdominal pain, edema, and history of allopurinol use has low C2/C4 complement levels. | Hereditary Angioedema (HAE) | Deficiency in C1 esterase inhibitor leads to uncontrolled kallikrein activity and excessive bradykinin production, causing angioedema. |
| A patient on an anti-psychotic medication develops a progressive decline in muscle strength, particularly proximal weakness, exacerbated by repeated attempts to stand up. | Lambert-Eaton Myasthenic Syndrome (LEMS) | Autoantibodies target presynaptic voltage-gated calcium channels, impairing acetylcholine release at the neuromuscular junction. |
Differential diagnosis / distinguishing features
Genetic Syndromes: PWS vs Angelman Syndrome
| Key Features | Distinguishing Findings | Next Step |
| Prader-Willi Syndrome (PWS) | Hyperphagia/Obesity, mild ID, almond eyes; Loss of paternal gene on Chr 15. | Genetic testing for imprinting defect or uniparental disomy. |
| Angelman Syndrome (AS) | Developmental delay, ataxia, "happy demeanor"; Loss of maternal gene on Chr 15. | Genetic testing for imprinting defect or uniparental disomy. |
Anti-psychotic Toxicities: Clozapine vs Quetiapine vs Olanzapine
| Key Features | Distinguishing Findings | Next Step |
| Clozapine | Myocarditis, Dilated Cardiomyopathy; Agranulocytosis risk. | Monitor ANC count closely (mandatory blood monitoring). |
| Quetiapine | Cataract formation ("Quinaurex"); Sedation/Orthostatic hypotension. | Counsel patient on visual changes and monitor for falls. |
| Olanzapine | Metabolic Syndrome (weight gain, hyperglycemia); Increased A1 C. | Monitor metabolic parameters; consider lifestyle modification or alternative agent. |
Management pearls
- For suspected Hereditary Angioedema (HAE) attacks, administer C1 esterase inhibitor replacement therapy (e.g., Bradykinin Binds).
- In the setting of heart failure, initiating RAAS blockade (AC Ei/ARB) and Beta-blockers must be done cautiously, often after initial stabilization with diuretics, to prevent acute renal compromise or hypotension.
- The primary treatment for CGD is Interferon gamma, which stimulates neutrophil function.
- For suspected Prader-Willi Syndrome, management focuses on controlling hyperphagia through strict dietary regimens and weight monitoring.
Don't miss
🚨
Genomic Imprinting: Remember that gene expression depends not just on the presence of a gene, but also on which parent contributed it (paternal vs maternal).
🚨
Coriocarcinoma Marker: The tumor marker is \beta-hCG; elevated levels can cross-react with TSH receptors, causing iatrogenic hyperthyroidism.
🚨
LEMS Diagnosis: The hallmark electrophysiological finding is the increased amplitude of muscle action potential when stimulated at high frequencies (e.g., 20 Hz) compared to low frequencies (e.g., 10 Hz).
🚨
HAE Treatment: Use bradykinin receptor antagonists (like Icatiband) or C1 esterase inhibitor replacement, as these directly address the excessive bradykinin accumulation.
Integration & clinical reasoning
- Endocrinology/Genetics Integration: The hypocalcemia seen in DiGeorge syndrome is a direct result of parathyroid gland agenesis due to failure of pharyngeal pouch development (a structural defect).
- Pharmacology/Cardiology Integration: Anti-psychotic drugs can cause cardiac toxicity (Clozapine -> DCM), necessitating careful monitoring and drug selection, especially in patients with pre-existing heart disease.
- Immunology/Genetics Integration: Both CGD and LAD are primary immunodeficiency states that affect specific immune cells (neutrophils) through defects in adhesion or oxidase function, respectively.
OMM / COMLEX integration
🦴
For COMLEX: know these viscerosomatics / Chapman points, but don't let OMM distract from emergent diagnosis and management.
- Acute/Unstable Management Priority: In any acute presentation (e.g., suspected myocarditis, severe abdominal pain), standard emergency management (ABCDE approach) takes absolute priority over OMT.
- Myocarditis: If a patient presents with signs of myocardial inflammation (myocarditis) secondary to medication (e.g., Clozapine), the immediate focus is supportive care and drug cessation; cardiac imaging/biopsy guides diagnosis, not OMT.
Concept connections / cross-references
- For detailed review of the endocrine system and pituitary hormones: Divine Intervention Episode 185.
- For comprehensive coverage of infectious diseases and immunology: Divine Intervention Episode 179.
High-yield association table
| Condition | Association | Mechanism | Clinical Significance |
| Prader-Willi Syndrome | Paternal gene loss on Chr 15q11-q13 | Loss of paternally expressed genes (imprinting defect). | Leads to hyperphagia, obesity, and developmental delay. |
| Angelman Syndrome | Maternal gene loss on Chr 15q11-q13 | Loss of maternally expressed genes (imprinting defect). | Associated with ataxia, microcephaly, and a characteristic "happy" demeanor. |
| Coriocarcinoma | Gestational Trophoblastic Disease (GTD) history | Arises from trophoblastic tissue; -hCG is the tumor marker. | High risk of metastasis to lungs; responds well to methotrexate. |
| Lambert-Eaton Myasthenic Syndrome | Autoantibodies against presynaptic voltage-gated calcium channels | Impaired release of acetylcholine (A Ch) at the neuromuscular junction. | Diagnosis requires electrophysiology showing facilitation with high-frequency stimulation. |
Key terms glossary
| Term | Definition | Context | Example |
| Genomic Imprinting | Epigenetic mechanism where gene expression depends on the parent of origin (maternal vs paternal). | Used to explain syndromes like PWS and AS. | A mutation in a paternally expressed gene causes PWS symptoms. |
| Hyperphagia | Excessive, uncontrollable appetite leading to obesity. | Hallmark symptom of Prader-Willi Syndrome. | Requires strict dietary control for management. |
| -hCG | Human chorionic gonadotropin; hormone marker. | Used as a tumor marker for Gestational Trophoblastic Disease and Coriocarcinoma. | Elevated levels can mimic hyperthyroidism by stimulating TSH receptors. |
| Bradykinin Receptor Antagonist | Drug class that blocks the action of bradykinin. | Treatment for Hereditary Angioedema (HAE). | Icatiband or Ecallantide are examples used to prevent excessive edema. |
Study optimization
| Topic | Study Approach | Priority | Resources |
| Immunodeficiency | Focus on the specific cell type affected and the underlying genetic/molecular defect. | High | Review flowcharts comparing different immunodeficiencies (e.g., SCID vs Hyper-IgM). |
| Genetic Syndromes | Master the concept of genomic imprinting: which parent's gene is lost or mutated in a given sex? | Medium-High | Use mnemonic devices to link syndromes (PWS/AS) to chromosome 15 and parental origin. |
| Pharmacology | Create side effect tables for anti-psychotics, linking the drug name to the specific organ system toxicity. | High | Focus on "red flag" toxicities: Clozapine -> Myocarditis; Quetiapine -> Cataract. |
Question pattern recognition
- The "What is Defective?" Pattern: When presented with a syndrome (e.g., CGD, LAD), the question often asks for the specific cell type or molecule that fails (neutrophil adhesion, T-cell maturation).
- The "Which Drug Causes X?" Pattern: Identifying drug toxicities (e.g., Clozapine -> DCM; Spironolactone -> Gynecomastia) is a common board trap.
- The "Differential Diagnosis" Pattern: Comparing syndromes with similar presentations (PWS vs AS, or various immunodeficiencies).
Test yourself
Common mistakes to avoid
🚫
Mistake 1: Confusing the cause of hypocalcemia. Hypocalcemia in DiGeorge syndrome is due to hypoparathyroidism (parathyroid gland agenesis), not primary parathyroid failure or Vitamin D deficiency.
🚫
Mistake 2: Assuming all immunodeficiencies affect T cells. While SCID affects T cells, CGD specifically targets the neutrophil function via NADPH oxidase deficiency.
🚫
Mistake 3: Misremembering drug side effects. Do not confuse Clozapine's risk of myocarditis with other anti-psychotic toxicities (e.g., Haloperidol -> hyperprolactinemia).
Common traps
⚠️
Trap 1: The "Allergic" Trap: Assuming that all recurrent infections in a child are due to an allergy or immune deficiency when the underlying cause might be structural (like DiGeorge syndrome) or genetic (like CGD). Always consider the specific cell type affected.
⚠️
Trap 2: The "Single Gene Defect" Trap: Thinking that PWS/AS is simply a single gene mutation, ignoring the critical concept of genomic imprinting and uniparental disomy.
⚠️
Trap 3: Overlooking the Mechanism in HAE: Assuming angioedema is due to complement deficiency when it is primarily due to excessive bradykinin accumulation from C1 esterase inhibitor deficiency.